Similar trends with significant passive and minor active tumor targeting were demonstrated for prostate-specific membrane antigen (PSMA)-targeted polylactic acid (PLA) and non-targeted control nanoparticles with a size of approximately 100 nm [41]. Here, FOLH1 is linked to neoplasm.